Liberia to receive Ebola trial drug

A trial of a potential drug to treat Ebola has started at a Medecins Sans Frontieres centre in Liberia.

The first large-scale trials of an experimental vaccine against the deadly Ebola virus are due to begin in Liberia.

New GDP Estimates Show International Support Vital to Speed Recovery

The World Bank Group (WBG) announced today that it would provide at least US$650 million during the next 12 to 18 months to help Guinea, Liberia and Sierra Leone recover from the devastating social and economic impact of the Ebola crisis and advance their longer-term development needs. The new WBG pledge brings the organization’s total financing for Ebola response and recovery efforts to date to US$1.62 billion.

The...

Pharmaceutical firm to donate two million tablets of malaria drug to world's largest COVID-19 trial  Daily MailScientists search for effective COVID-19 treatments  Al Jazeera EnglishWhat do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life.  USA TODAYCoronavirus: Clinical trial of hydroxychloroquine for COVID-19 treatment begins in US  Gulf NewsTrump’s chloroquine hype is a misinformation problem bigger than social media  The VergeView Full coverage on Google...

US aid workers who contracted the deadly Ebola virus in Liberia appear to be improving after receiving an experimental drug, officials says.

The British volunteer nurse William Pooley, who contracted Ebola while working in Sierra Leone, has been given the experimental drug ZMapp.

The World Health Organisation has declared Liberia free of Ebola, after the country reached the milestone of no new cases in 42 days.

WAZIRI wa Habari nchini Liberia amekiri kuwa mfumo wa huduma za afya, umezidiwa kutokana na kasi ya kusambaa kwa virusi vya ugonjwa wa ebola nchini humo.

The charity MSF says it is to host clinical trials of new Ebola treatments in West Africa, targeting patients in the first 14 days of illness.